Shah, N. J., Bupathi, M., McKay, R. R., Garmezy, B., Emamekhoo, H., Gelmann, E. P., Picus, J., Curti, B. D., Figlin, R. A., Hammers, H. J., Lam, E. T., Barata, P. C., Hutson, T. E., Ornstein, M. C., Rank, B. H., Salkeni, M. A., Zhao, S., Chisamore, M. J., Bose, N., Motzer, R. J. (2026). A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with locally advanced (inoperable) or metastatic renal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4534